LivaNova/LIVN

$57.12

1.52%
-
1D1W1MYTD1YMAX

About LivaNova

LivaNova PLC is a global medical device company. The Company designs, develops, manufactures, and sells products and therapies to provide improvements for both the head and heart. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the development, production and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannulae and other related accessories. The Neuromodulation segment is engaged in the design, development, and marketing of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the LivaNova Vagus Nerve Stimulation Therapy (VNS Therapy) System, is an implantable device for the treatment of DRE and DTD. The ACS segment is engaged in the development, production, and sale of temporary life support products.
Ticker
LIVN
Sector
Healthcare
Trading on
NASDAQ
Industry
Medical Equipment & Supplies
CEO
William Kozy
Employees
2,900
Headquarters
London, United Kingdom

LivaNova Metrics

BasicAdvanced
$3.08B
Market cap
176.97
P/E ratio
$0.32
EPS
0.90
Beta
-
Dividend rate

What the Analysts think about LivaNova

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 9 analysts.
7.97% upside
High $82.00
Low $47.00
$57.12
Current price
$61.67
Average price target

LivaNova Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
5.28% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$310.1M
8.39%
Net income
$16.4M
-324.66%
Profit margin
5.28%
-307.06%

LivaNova Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 14.78%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q1 24
Actual
$0.43
$0.78
$0.73
-
Expected
$0.39
$0.54
$0.64
$0.49
Surprise
9.53%
44.61%
14.78%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell LivaNova stock

Buy or sell LivaNova stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing